Biotron Ltd (ASX: BIT) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
Biotron Ltd Chart and Price Data
Fundamentals Data provided by Morningstar.
Data provided by Morningstar.
Market Cap
$15.34 million
P/E Ratio
N/A
Dividend Yield
0.00%
Shares Outstanding
902.38 million
Earnings per share
-0.004
Dividend per share
N/A
Year To Date Return
-82.47%
Earnings Yield
N/A
Franking
-
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
Biotron Ltd (ASX: BIT)
Latest News
Share Gainers
These small cap ASX shares have surged higher on Thursday
Share Fallers
Biotron Limited (ASX:BIT) shares sank 27% lower on Wednesday
Share Fallers
Why these 4 ASX shares have started the week in the red
Share Gainers
The Biotron Limited (ASX:BIT) share price jumped 70% higher this week
Share Gainers
These 3 small cap ASX shares are ending the week on a high
Share Gainers
These 3 ASX shares are pushing higher on Wednesday
Share Gainers
Why these 4 ASX shares have started the week with a bang
Record Highs
The Biotron Limited (ASX:BIT) share price is up 800% in just two weeks
Share Market News
These 3 ASX small cap shares have stormed higher on Thursday
Share Gainers
These 3 small cap ASX shares are posting strong gains on Wednesday
Share Gainers
These 3 small cap ASX shares are on the rise on Tuesday
⏸️ Investing
5 of the best companies presenting at Australia Biotech Invest 2014
BIT ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About Biotron Ltd
Biotron Ltd is a biotechnology company. It is engaged in the funding and management of intermediate and applied biotechnology research and development projects. Its antiviral drug is BIT225, which is in Phase II clinical trials for the treatment of HIV-1 and hepatitis C virus infections. Geographically, it operates only in Australia through biotechnology segment.
BIT Share Price History Data provided by Morningstar.
| Date | Close | Change | % Change | Volume | Open | High | Low |
|---|---|---|---|---|---|---|---|
| 23 Dec 2024 | $0.02 | $0.00 | 0.00% | 206,082 | $0.02 | $0.02 | $0.02 |
| 20 Dec 2024 | $0.02 | $0.00 | 0.00% | 249,482 | $0.02 | $0.02 | $0.02 |
| 19 Dec 2024 | $0.02 | $0.00 | 0.00% | 1,986,476 | $0.02 | $0.02 | $0.02 |
| 18 Dec 2024 | $0.02 | $0.00 | 0.00% | 340,300 | $0.02 | $0.02 | $0.02 |
| 17 Dec 2024 | $0.02 | $0.00 | 0.00% | 59,235 | $0.02 | $0.02 | $0.02 |
| 16 Dec 2024 | $0.02 | $0.00 | 0.00% | 395,486 | $0.02 | $0.02 | $0.02 |
| 13 Dec 2024 | $0.02 | $0.00 | 0.00% | 1,249,754 | $0.02 | $0.02 | $0.02 |
| 12 Dec 2024 | $0.02 | $0.00 | 0.00% | 414,359 | $0.02 | $0.02 | $0.02 |
| 11 Dec 2024 | $0.02 | $0.00 | 0.00% | 52,484 | $0.02 | $0.02 | $0.02 |
| 10 Dec 2024 | $0.02 | $0.00 | 0.00% | 76,882 | $0.02 | $0.02 | $0.02 |
| 09 Dec 2024 | $0.02 | $0.00 | 0.00% | 40,978 | $0.02 | $0.02 | $0.02 |
| 06 Dec 2024 | $0.02 | $0.00 | 0.00% | 505,067 | $0.02 | $0.02 | $0.02 |
| 05 Dec 2024 | $0.02 | $0.00 | 0.00% | 206,637 | $0.02 | $0.02 | $0.02 |
| 04 Dec 2024 | $0.02 | $0.00 | 0.00% | 283,570 | $0.02 | $0.02 | $0.02 |
| 03 Dec 2024 | $0.02 | $0.00 | 0.00% | 342,619 | $0.02 | $0.02 | $0.02 |
| 02 Dec 2024 | $0.02 | $0.00 | 0.00% | 357,092 | $0.02 | $0.02 | $0.02 |
| 29 Nov 2024 | $0.02 | $0.00 | 0.00% | 2,872,644 | $0.02 | $0.02 | $0.02 |
| 28 Nov 2024 | $0.02 | $0.00 | 0.00% | 2,054,298 | $0.02 | $0.02 | $0.02 |
| 27 Nov 2024 | $0.02 | $0.00 | 0.00% | 3,342,293 | $0.02 | $0.02 | $0.02 |
Director Transactions Data provided by Morningstar.
| Date | Director | Type | Amount | Value | Notes |
|---|---|---|---|---|---|
| 25 Nov 2024 | Michael Hoy | Expiry | 934,780 | $17,760 |
Options expired.
|
| 25 Nov 2024 | Robert Thomas | Expiry | 268,403 | $5,099 |
Options expired.
|
| 25 Nov 2024 | Michelle Miller | Expiry | 315,000 | $5,985 |
Options expired. As per announcement on 28-11-2024
|
Directors & Management Data provided by Morningstar.
| Name | Title | Start Date | Profile |
|---|---|---|---|
| Mr Michael J Hoy | Non-Executive DirectorNon-Executive Chairman | Feb 2000 |
Mr Hoy has more than 30 years of corporate experience in Australia, the United Kingdom, USA and Asia. He is Chairman of Lipotek Pty Limited and a former director of John Fairfax Holdings Limited and FXF Trust.
|
| Mr Robert Bain Thomas | Non-Executive Director | Mar 2012 |
Mr Thomas has over 35 years of experience in the securities industry, with Potter Partners (now UBS), County NatWest and Citigroup. He is the chairman of Starpharma Holdings Limited and a director of Clarity Pharmaceuticals Limited. He chairs Grahger Securities Pty Ltd and is a director of O'Connell Street Associates Pty Limited.
|
| Dr Michelle Miller | Managing Director | Jun 2002 |
Dr Miller has worked for over 25 years in the bioscience industry, with experience in commercial drug development. Her experience includes several years at Johnson & Johnson developing anti-HIV gene therapeutics through preclinical research to clinical trials. She has finance industry experience from time spent as an Investment Manager with a specialist bioscience venture capital fund.
|
| Mr Peter James Nightingale | Company Secretary | Feb 1999 |
-
|
| Peter James Nightingale | Company Secretary |
-
|
Top Shareholders Data provided by Morningstar.
| Name | Shares | Capital |
|---|---|---|
| Rookharp Capital Pty Limited | 26,920,201 | 2.98% |
| Jey Investment Pty Ltd | 24,240,000 | 2.69% |
| Umbiram Pty Ltd <Michael Hoy Superfund A/C> | 11,217,352 | 1.24% |
| Fordholm Investments Pty Ltd <Fordholm Super Fund A/C> | 10,300,000 | 1.14% |
| Citicorp Nominees Pty Limited | 10,201,698 | 1.13% |
| Dr Angela Fay Dulhunty | 10,000,000 | 1.11% |
| Dr Huy Tran | 9,699,357 | 1.07% |
| Dns Accounting And Law Consultancy Pty Ltd | 8,359,582 | 0.93% |
| Attollo Copia Pty Ltd <F A Pires Super Fund A/C> | 7,620,678 | 0.84% |
| Pathold No 222 Pty Ltd | 7,600,000 | 0.84% |
| Armco Barriers Pty Ltd | 7,550,000 | 0.84% |
| Mr William John Dunn | 7,300,000 | 0.81% |
| Edstop Pty Limited <Superannuation Fund A/C> | 6,045,906 | 0.67% |
| Standby Forty Six Pty Limited | 5,600,000 | 0.62% |
| Vicex Holdings Proprietary Limited <Vicex Super A/C> | 5,600,000 | 0.62% |
| Scotts A V Pty Ltd <Scotts Acorn Emp S/F A/C> | 4,918,000 | 0.55% |
| Mr Travis Paul Gloury | 4,819,355 | 0.53% |
| Mr Charles Tollios Panos | 4,338,928 | 0.48% |
| Mr Peter James Nightingale | 4,313,884 | 0.48% |
| Mr Mark Andrew Peterson | 4,263,157 | 0.48% |
